Tian'an Technology Group Ltd (OTC: TANAF)

Tian’an Technology Group Ltd. is a holding company that conducts its operations through subsidiaries engaged in power control systems graphene based health therapy products and healthcare services. Initially focused on power control for low speed electric vehicles the company shifted its emphasis to graphene far infrared therapy in the third quarter of 2022 and later established a healthcare services subsidiary in the third quarter of 2024.

The company generates revenue primarily from the sale of its graphene far infrared therapy products, which include energy rooms, heating blankets, pillows, knee pads, knee compartments, moxibustion instruments, and eye masks, and from healthcare service fees earned through its Henan Qige subsidiary. Sales are conducted under agreements that require full payment before shipment while wholesale customers may receive a 30 day payment period. Service revenue is derived from fees charged for wellness and medical support provided to individuals and institutions.

The company operates through the following segments.

• Power Control and Service Systems: This segment involves the design manufacture and sale of power control and service system solutions for low speed electric vehicles such as electric forklifts, golf carts, street sweepers, and other specialized field vehicles. Its core product line consists of brushless DC motor controllers that are paired with brushless DC motors widely used in industrial applications worldwide. The segment’s revenue historically came from technology driven sales of these control systems before the company’s strategic shift to graphene based health therapy products.

• Graphene Health Therapy Products: This segment develops and markets a range of graphene based far infrared therapy devices that exploit the material’s uniform heating rapid response and low energy consumption. Products include an energy room resembling a sauna, a heating blanket, a therapeutic pillow, knee compartments, knee pads, an intelligent moxibustion instrument, and an eye mask, each designed to emit far infrared radiation with a wavelength of 6 14 µm that mirrors the infrared spectrum of the human body. The segment emphasizes the therapeutic benefits of improved microcirculation, pain relief, and muscle relaxation, and it leverages partnerships with suppliers such as Xiwang New Materials Technology Co., Ltd. for raw graphene and technical support.

• Healthcare Services: Through its subsidiary Henan Qige the company has entered the healthcare service sector to offer wellness and medical support programs that complement its graphene based therapy products. Services include personalized health consultations, guided therapy sessions using the far infrared devices, and after sales technical assistance aimed at ensuring optimal product use and customer satisfaction. The segment targets individuals seeking preventive care, wellness centers, and clinics that wish to integrate advanced therapy modalities into their offerings.

Within the graphene and health therapy industries Tian’an Technology Group Ltd. positions itself as a niche provider of far infrared therapy solutions benefiting from proprietary technology that harnesses the uniform heating and low energy attributes of graphene. The global graphene market was valued at approximately $11.789 billion in 2023 and is projected to reach about $51.835 billion by 2030 reflecting a compound annual growth rate of 23.56 percent. The Asia Pacific region accounted for the largest share in 2022 with revenue of $67.8 million and a forecast CAGR of 51.0 percent while China alone is expected to grow at a CAGR of 60.9 percent in volume terms. These dynamics create a sizable addressable market for the company’s products. Competitors include established graphene producers such as Haydale Graphene Industries PLC, Directa Plus, and Applied Graphene Materials as well as health device firms offering infrared based therapy equipment. Tian’an differentiates itself through its focus on therapeutic applications, a diversified product portfolio, and strategic relationships with material suppliers that secure a steady supply of high quality graphene.

The company serves individual consumers who purchase its graphene far infrared therapy products for home use, wellness centers that offer the devices as part of their service menus, and clinics that integrate the technology into patient care programs. In addition it supplies wholesale distributors who resell the products to retailers and end users. While the filing does not disclose specific customer names the description indicates a business to consumer orientation supported by a business to broad distribution network.